id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0402-0019,FDA,FDA-2013-N-0402,"Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives;
Public Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,2014-06-14T03:59:59Z,2014-06-15T00:48:15Z,2014-03986,0,0,09000064815c3a9e